Report Publication Announcement • Apr 13, 2016
Report Publication Announcement
Open in ViewerOpens in native device viewer
STOCKHOLM – 13 April 2016. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces publication of its Annual Report 2015.
The report is now available to download at www.karolinskadevelopment.com
Jim Van heusden, CEO, Karolinska Development AB Phone: +46 72 858 32 09, e-mail: [email protected]
David Dible/Mark Swallow/Pip Batty, Citigate Dewe Rogerson Phone: +44 20 7638 9571; e-mail: [email protected]
Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients' lives and provide an attractive return on investment.
Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and cofunded by specialist international investors, to provide the greatest chance of success.
Karolinska Development's investee portfolio comprises 12 companies biotech and medtech targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.
The Company is led by a team of investment professionals with strong venture capital backgrounds, experienced company builders and entrepreneurs, with access to a strong global network.
For more information, please visit www.karolinskadevelopment.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.